Real-time enrollment status for this geographic atrophy secondary to age-related macular degeneration clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:52 AM UTC
| NCT Number | NCT06990269 |
| Recruiting Status | Recruiting |
| Condition | Geographic Atrophy Secondary to Age-related Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 19 sites in the US |
| Sponsor | ADARx Pharmaceuticals, Inc. |
| Last Updated on CT.gov | June 16, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT06990269 is currently recruiting participants. This clinical trial study for geographic atrophy secondary to age-related macular degeneration is actively seeking new participants at 19 locations across the United States. The study is sponsored by ADARx Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06990269 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06990269 was last updated 3 weeks ago (June 16, 2026). HelloStudys verifies this status automatically.